-
2
-
-
0034659906
-
World Health Organization classification of tumors
-
P. Kleihues, and L.H. Sobin World Health Organization classification of tumors Cancer 88 2000 2887
-
(2000)
Cancer
, vol.88
, pp. 2887
-
-
Kleihues, P.1
Sobin, L.H.2
-
3
-
-
26944473246
-
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment
-
B.K. Edwards, M.L. Brown, and P.A. Wingo Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment J Natl Cancer Inst 97 2005 1407 1427
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1407-1427
-
-
Edwards, B.K.1
Brown, M.L.2
Wingo, P.A.3
-
4
-
-
79960111080
-
Phase II study of aflibercept in recurrent malignant glioma: A North American Brain Tumor Consortium study
-
J.F. de Groot, K.R. Lamborn, and S.M. Chang Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study J Clin Oncol 29 2011 2689 2695
-
(2011)
J Clin Oncol
, vol.29
, pp. 2689-2695
-
-
De Groot, J.F.1
Lamborn, K.R.2
Chang, S.M.3
-
5
-
-
79959956310
-
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03
-
F.M. Iwamoto, K.R. Lamborn, and J.G. Kuhn A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03 Neuro Oncol 13 2011 509 516
-
(2011)
Neuro Oncol
, vol.13
, pp. 509-516
-
-
Iwamoto, F.M.1
Lamborn, K.R.2
Kuhn, J.G.3
-
6
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
-
(2005)
N Engl J Med
, vol.352
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
Van Den Bent, M.J.3
-
7
-
-
33845317573
-
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
-
S. Bao, Q. Wu, and R.E. McLendon Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 444 2006 756 760
-
(2006)
Nature
, vol.444
, pp. 756-760
-
-
Bao, S.1
Wu, Q.2
McLendon, R.E.3
-
8
-
-
0034741232
-
Treatment of malignant glioma: A problem beyond the margins of resection
-
A. Giese, and M. Westphal Treatment of malignant glioma: a problem beyond the margins of resection J Cancer Res Clin Oncol 127 2001 217 225
-
(2001)
J Cancer Res Clin Oncol
, vol.127
, pp. 217-225
-
-
Giese, A.1
Westphal, M.2
-
9
-
-
41049103648
-
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: A North American Brain Tumor Consortium study
-
M.D. Prados, W.K. Yung, and P.Y. Wen Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American Brain Tumor Consortium study Cancer Chemother Pharmacol 61 2008 1059 1067
-
(2008)
Cancer Chemother Pharmacol
, vol.61
, pp. 1059-1067
-
-
Prados, M.D.1
Yung, W.K.2
Wen, P.Y.3
-
10
-
-
36048994736
-
Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment
-
D.B. Hoelzinger, T. Demuth, and M.E. Berens Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment J Natl Cancer Inst 99 2007 1583 1593
-
(2007)
J Natl Cancer Inst
, vol.99
, pp. 1583-1593
-
-
Hoelzinger, D.B.1
Demuth, T.2
Berens, M.E.3
-
11
-
-
68549107801
-
Invadopodia: Specialized tumor cell structures for the focal degradation of the extracellular matrix
-
R. Buccione, G. Caldieri, and I. Ayala Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix Cancer Metastasis Rev 28 2009 137 149
-
(2009)
Cancer Metastasis Rev
, vol.28
, pp. 137-149
-
-
Buccione, R.1
Caldieri, G.2
Ayala, I.3
-
12
-
-
43049126506
-
Invadopodia
-
A.M. Weaver Invadopodia Curr Biol 18 2008 R362 R364
-
(2008)
Curr Biol
, vol.18
-
-
Weaver, A.M.1
-
13
-
-
44249097734
-
Invadopodia: At the cutting edge of tumour invasion
-
S.S. Stylli, A.H. Kaye, and P. Lock Invadopodia: at the cutting edge of tumour invasion J Clin Neurosci 15 2008 725 737
-
(2008)
J Clin Neurosci
, vol.15
, pp. 725-737
-
-
Stylli, S.S.1
Kaye, A.H.2
Lock, P.3
-
15
-
-
8544283078
-
Role of synaptojanin 2 in glioma cell migration and invasion
-
Y.Y. Chuang, N.L. Tran, and N. Rusk Role of synaptojanin 2 in glioma cell migration and invasion Cancer Res 64 2004 8271 8275
-
(2004)
Cancer Res
, vol.64
, pp. 8271-8275
-
-
Chuang, Y.Y.1
Tran, N.L.2
Rusk, N.3
-
16
-
-
79959541003
-
The 'ins' and 'outs' of podosomes and invadopodia: Characteristics, formation and function
-
D.A. Murphy, and S.A. Courtneidge The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function Nat Rev Mol Cell Biol 12 2011 413 426
-
(2011)
Nat Rev Mol Cell Biol
, vol.12
, pp. 413-426
-
-
Murphy, D.A.1
Courtneidge, S.A.2
-
17
-
-
0032480013
-
A new method for isolating tyrosine kinase substrates used to identify fish, an SH3 and PX domain-containing protein, and Src substrate
-
P. Lock, C.L. Abram, and T. Gibson A new method for isolating tyrosine kinase substrates used to identify fish, an SH3 and PX domain-containing protein, and Src substrate Embo J 17 1998 4346 4357
-
(1998)
Embo J
, vol.17
, pp. 4346-4357
-
-
Lock, P.1
Abram, C.L.2
Gibson, T.3
-
18
-
-
0037930878
-
The adaptor protein fish associates with members of the ADAMs family and localizes to podosomes of Src-transformed cells
-
C.L. Abram, D.F. Seals, and I. Pass The adaptor protein fish associates with members of the ADAMs family and localizes to podosomes of Src-transformed cells J Biol Chem 278 2003 16844 16851
-
(2003)
J Biol Chem
, vol.278
, pp. 16844-16851
-
-
Abram, C.L.1
Seals, D.F.2
Pass, I.3
-
19
-
-
13844264301
-
The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells
-
D.F. Seals, E.F. Azucena Jr., and I. Pass The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells Cancer Cell 7 2005 155 165
-
(2005)
Cancer Cell
, vol.7
, pp. 155-165
-
-
Seals, D.F.1
Azucena Jr., E.F.2
Pass, I.3
-
20
-
-
69449096397
-
Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation
-
M. Oser, H. Yamaguchi, and C.C. Mader Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation J Cell Biol 186 2009 571 587
-
(2009)
J Cell Biol
, vol.186
, pp. 571-587
-
-
Oser, M.1
Yamaguchi, H.2
Mader, C.C.3
-
21
-
-
49049105452
-
A role for the podosome/invadopodia scaffold protein Tks5 in tumor growth in vivo
-
B. Blouw, D.F. Seals, and I. Pass A role for the podosome/invadopodia scaffold protein Tks5 in tumor growth in vivo Eur J Cell Biol 87 2008 555 567
-
(2008)
Eur J Cell Biol
, vol.87
, pp. 555-567
-
-
Blouw, B.1
Seals, D.F.2
Pass, I.3
-
22
-
-
47549105130
-
Sequential signals toward podosome formation in NIH-src cells
-
T. Oikawa, T. Itoh, and T. Takenawa Sequential signals toward podosome formation in NIH-src cells J Cell Biol 182 2008 157 169
-
(2008)
J Cell Biol
, vol.182
, pp. 157-169
-
-
Oikawa, T.1
Itoh, T.2
Takenawa, T.3
-
23
-
-
69549122682
-
Nck adaptor proteins link Tks5 to invadopodia actin regulation and ECM degradation
-
S.S. Stylli, T.T. Stacey, and A.M. Verhagen Nck adaptor proteins link Tks5 to invadopodia actin regulation and ECM degradation J Cell Sci 122 2009 2727 2740
-
(2009)
J Cell Sci
, vol.122
, pp. 2727-2740
-
-
Stylli, S.S.1
Stacey, T.T.2
Verhagen, A.M.3
-
24
-
-
13444301091
-
Molecular mechanisms of invadopodium formation: The role of the N-WASP-Arp2/3 complex pathway and cofilin
-
H. Yamaguchi, M. Lorenz, and S. Kempiak Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin J Cell Biol 168 2005 441 452
-
(2005)
J Cell Biol
, vol.168
, pp. 441-452
-
-
Yamaguchi, H.1
Lorenz, M.2
Kempiak, S.3
-
25
-
-
0037341569
-
Dynamin participates in focal extracellular matrix degradation by invasive cells
-
M. Baldassarre, A. Pompeo, and G. Beznoussenko Dynamin participates in focal extracellular matrix degradation by invasive cells Mol Biol Cell 14 2003 1074 1084
-
(2003)
Mol Biol Cell
, vol.14
, pp. 1074-1084
-
-
Baldassarre, M.1
Pompeo, A.2
Beznoussenko, G.3
-
26
-
-
79960734896
-
A Src-Tks5 pathway is required for neural crest cell migration during embryonic development
-
D.A. Murphy, B. Diaz, and P.A. Bromann A Src-Tks5 pathway is required for neural crest cell migration during embryonic development PLoS ONE 6 2011 e22499
-
(2011)
PLoS ONE
, vol.6
, pp. 22499
-
-
Murphy, D.A.1
Diaz, B.2
Bromann, P.A.3
-
27
-
-
79952499030
-
Twist1-induced invadopodia formation promotes tumor metastasis
-
M.A. Eckert, T.M. Lwin, and A.T. Chang Twist1-induced invadopodia formation promotes tumor metastasis Cancer Cell 19 2011 372 386
-
(2011)
Cancer Cell
, vol.19
, pp. 372-386
-
-
Eckert, M.A.1
Lwin, T.M.2
Chang, A.T.3
-
28
-
-
33645507413
-
Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: Defining the stages of invadopodia formation and function
-
V.V. Artym, Y. Zhang, and F. Seillier-Moiseiwitsch Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function Cancer Res 66 2006 3034 3043
-
(2006)
Cancer Res
, vol.66
, pp. 3034-3043
-
-
Artym, V.V.1
Zhang, Y.2
Seillier-Moiseiwitsch, F.3
-
29
-
-
34249320529
-
Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia
-
E.S. Clark, A.S. Whigham, and W.G. Yarbrough Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia Cancer Res 67 2007 4227 4235
-
(2007)
Cancer Res
, vol.67
, pp. 4227-4235
-
-
Clark, E.S.1
Whigham, A.S.2
Yarbrough, W.G.3
-
30
-
-
78149323428
-
Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia
-
M. Oser, C.C. Mader, and H. Gil-Henn Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia J Cell Sci 123 2010 3662 3673
-
(2010)
J Cell Sci
, vol.123
, pp. 3662-3673
-
-
Oser, M.1
Mader, C.C.2
Gil-Henn, H.3
-
31
-
-
79851499472
-
Cortactin in breast cancer: Analysis with tissue microarray
-
S.M. Sheen-Chen, C.Y. Huang, and Y.Y. Liu Cortactin in breast cancer: analysis with tissue microarray Anticancer Res 31 2011 293 297
-
(2011)
Anticancer Res
, vol.31
, pp. 293-297
-
-
Sheen-Chen, S.M.1
Huang, C.Y.2
Liu, Y.Y.3
-
32
-
-
76349088746
-
Cytoskeleton alterations in melanoma: Aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression
-
X.Z. Xu, M.V. Garcia, and T.Y. Li Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression Mod Pathol 23 2010 187 196
-
(2010)
Mod Pathol
, vol.23
, pp. 187-196
-
-
Xu, X.Z.1
Garcia, M.V.2
Li, T.Y.3
-
33
-
-
40349096416
-
Cortactin expression predicts poor survival in laryngeal carcinoma
-
J.H. Gibcus, M.F. Mastik, and L. Menkema Cortactin expression predicts poor survival in laryngeal carcinoma Br J Cancer 98 2008 950 955
-
(2008)
Br J Cancer
, vol.98
, pp. 950-955
-
-
Gibcus, J.H.1
Mastik, M.F.2
Menkema, L.3
-
34
-
-
40349116256
-
Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: Comparison with epidermal growth factor receptor status
-
P. Hofman, C. Butori, and K. Havet Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status Br J Cancer 98 2008 956 964
-
(2008)
Br J Cancer
, vol.98
, pp. 956-964
-
-
Hofman, P.1
Butori, C.2
Havet, K.3
-
35
-
-
67349137902
-
The EGFRvIII variant in glioblastoma multiforme
-
H.K. Gan, A.H. Kaye, and R.B. Luwor The EGFRvIII variant in glioblastoma multiforme J Clin Neurosci 16 2009 748 754
-
(2009)
J Clin Neurosci
, vol.16
, pp. 748-754
-
-
Gan, H.K.1
Kaye, A.H.2
Luwor, R.B.3
-
36
-
-
0142188691
-
Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme
-
N. Shinojima, K. Tada, and S. Shiraishi Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme Cancer Res 63 2003 6962 6970
-
(2003)
Cancer Res
, vol.63
, pp. 6962-6970
-
-
Shinojima, N.1
Tada, K.2
Shiraishi, S.3
-
37
-
-
0030017885
-
Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas
-
discussion 23-4
-
K. Watanabe, O. Tachibana, and K. Sata Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas Brain Pathol 6 1996 217 223 discussion 23-4
-
(1996)
Brain Pathol
, vol.6
, pp. 217-223
-
-
Watanabe, K.1
Tachibana, O.2
Sata, K.3
-
38
-
-
3142660253
-
Photodynamic therapy of brain tumours: Evaluation of porphyrin uptake versus clinical outcome
-
S.S. Stylli, M. Howes, and L. MacGregor Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome J Clin Neurosci 11 2004 584 596
-
(2004)
J Clin Neurosci
, vol.11
, pp. 584-596
-
-
Stylli, S.S.1
Howes, M.2
MacGregor, L.3
-
39
-
-
33748467188
-
Photodynamic therapy of cerebral glioma - A review. Part II - Clinical studies
-
S.S. Stylli, and A.H. Kaye Photodynamic therapy of cerebral glioma - a review. Part II - clinical studies J Clin Neurosci 13 2006 709 717
-
(2006)
J Clin Neurosci
, vol.13
, pp. 709-717
-
-
Stylli, S.S.1
Kaye, A.H.2
-
40
-
-
19744362839
-
Photodynamic therapy of high grade glioma - Long term survival
-
S.S. Stylli, A.H. Kaye, and L. MacGregor Photodynamic therapy of high grade glioma - long term survival J Clin Neurosci 12 2005 389 398
-
(2005)
J Clin Neurosci
, vol.12
, pp. 389-398
-
-
Stylli, S.S.1
Kaye, A.H.2
MacGregor, L.3
-
41
-
-
0037318729
-
Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma
-
B.Z. Yuan, X. Zhou, and D.B. Zimonjic Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma J Mol Diagn 5 2003 48 53
-
(2003)
J Mol Diagn
, vol.5
, pp. 48-53
-
-
Yuan, B.Z.1
Zhou, X.2
Zimonjic, D.B.3
-
42
-
-
33846225205
-
Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance
-
M.L. Luo, X.M. Shen, and Y. Zhang Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance Cancer Res 66 2006 11690 11699
-
(2006)
Cancer Res
, vol.66
, pp. 11690-11699
-
-
Luo, M.L.1
Shen, X.M.2
Zhang, Y.3
-
43
-
-
78149431662
-
Cortactin, fascin and survivin expression associated with clinicopathological parameters in brain gliosarcoma
-
J.H. Chen, K.Y. Chen, and H.I. Ma Cortactin, fascin and survivin expression associated with clinicopathological parameters in brain gliosarcoma Chin J Physiol 53 2010 234 244
-
(2010)
Chin J Physiol
, vol.53
, pp. 234-244
-
-
Chen, J.H.1
Chen, K.Y.2
Ma, H.I.3
-
44
-
-
80051469653
-
Pathologic significance and prognostic value of phosphorylated cortactin expression in patients with sarcomatoid renal cell carcinoma
-
T. Matsuo, Y. Miyata, and S. Watanabe Pathologic significance and prognostic value of phosphorylated cortactin expression in patients with sarcomatoid renal cell carcinoma Urology 78 2011 476e9 476e15
-
(2011)
Urology
, vol.78
-
-
Matsuo, T.1
Miyata, Y.2
Watanabe, S.3
-
45
-
-
0038498066
-
A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton
-
D.K. Lynch, S.C. Winata, and R.J. Lyons A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton J Biol Chem 278 2003 21805 21813
-
(2003)
J Biol Chem
, vol.278
, pp. 21805-21813
-
-
Lynch, D.K.1
Winata, S.C.2
Lyons, R.J.3
-
46
-
-
0038784546
-
Membrane type i matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix
-
K.B. Hotary, E.D. Allen, and P.C. Brooks Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix Cell 114 2003 33 45
-
(2003)
Cell
, vol.114
, pp. 33-45
-
-
Hotary, K.B.1
Allen, E.D.2
Brooks, P.C.3
|